BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 19179508)

  • 1. Cancer. HPV casts a wider shadow.
    Zelkowitz R
    Science; 2009 Jan; 323(5914):580-1. PubMed ID: 19179508
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tonsillar and oral cancer should be considered in the discussion on HPV vaccine].
    Andersson G; Hasson BG; Rosenquist K; Schildt EB; Wennerberg J
    Lakartidningen; 2007 Jan 24-30; 104(4):257-8; author reply 258-9. PubMed ID: 17328475
    [No Abstract]   [Full Text] [Related]  

  • 3. [Implementation of HPV vaccination in Germany].
    Schreckenberger C; Kaufmann AM; Schneider A
    Dtsch Med Wochenschr; 2007 Oct; 132(42):2221-4. PubMed ID: 17926251
    [No Abstract]   [Full Text] [Related]  

  • 4. [Involvement of human papillomavirus in upper aero-digestive tracts cancers].
    Neufcoeur PE; Arafa M; Delvenne P; Saussez S
    Bull Cancer; 2009 Oct; 96(10):941-50. PubMed ID: 19744917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Papillomavirus and head and neck cancer].
    Lescaille G; Descroix V; Azérad J
    Rev Stomatol Chir Maxillofac; 2011 Jun; 112(3):160-3. PubMed ID: 21596407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The human papillomavirus vaccine: is it of value in dermatology?].
    Pedragosa-Jové R; Salleras-Redonet M;
    Actas Dermosifiliogr; 2012 Mar; 103(2):92-3. PubMed ID: 22296714
    [No Abstract]   [Full Text] [Related]  

  • 7. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.
    Gillison ML; D'Souza G; Westra W; Sugar E; Xiao W; Begum S; Viscidi R
    J Natl Cancer Inst; 2008 Mar; 100(6):407-20. PubMed ID: 18334711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV's new targets. The head, neck and oral cavity.
    Gisvold C
    Adv NPs PAs; 2013 Mar; 4(3):31-3. PubMed ID: 23516748
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of high-risk human papillomavirus type 16/18 in cutaneous warts in immunocompetent patients, using polymerase chain reaction.
    Payal R; Gupta S; Aggarwal R; Handa S; Radotra BD; Arora SK
    Dermatol Online J; 2006 Oct; 12(6):1. PubMed ID: 17083881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?
    Sturgis EM; Cinciripini PM
    Cancer; 2007 Oct; 110(7):1429-35. PubMed ID: 17724670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High association of human papillomavirus infection with oral cancer: a case-control study.
    Anaya-Saavedra G; Ramírez-Amador V; Irigoyen-Camacho ME; García-Cuellar CM; Guido-Jiménez M; Méndez-Martínez R; García-Carrancá A
    Arch Med Res; 2008 Feb; 39(2):189-97. PubMed ID: 18164962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of human papillomavirus types 16 and 18 in the general population in Taiwan: implication for optimal age of human papillomavirus vaccination.
    Chen CJ; Viscidi RP; Chuang CH; Huang YC; Chiu CH; Lin TY
    J Clin Virol; 2007 Feb; 38(2):126-30. PubMed ID: 17210269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus genotype distributions inform screening and vaccination policy.
    Pinkowish MD
    CA Cancer J Clin; 2009; 59(5):280-1. PubMed ID: 19684300
    [No Abstract]   [Full Text] [Related]  

  • 14. Human papillomavirus as a risk factor in oral carcinogenesis: a study using in situ hybridization with signal amplification.
    Acay R; Rezende N; Fontes A; Aburad A; Nunes F; Sousa S
    Oral Microbiol Immunol; 2008 Aug; 23(4):271-4. PubMed ID: 18582325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging oral cancer subtype draws concern.
    Garg A; Guez G
    Dent Implantol Update; 2010 Oct; 21(10):73-7. PubMed ID: 20968172
    [No Abstract]   [Full Text] [Related]  

  • 16. Behavioral and sociodemographic risk factors for serological and DNA evidence of HPV6, 11, 16, 18 infections.
    Wiley DJ; Masongsong EV; Lu S; Heather L S; Salem B; Giuliano AR; Ault KA; Haupt RM; Brown DR
    Cancer Epidemiol; 2012 Jun; 36(3):e183-9. PubMed ID: 22277329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demographic and risk factors in patients with head and neck tumors.
    Tachezy R; Klozar J; Rubenstein L; Smith E; Saláková M; Smahelová J; Ludvíková V; Rotnáglová E; Kodet R; Hamsíková E
    J Med Virol; 2009 May; 81(5):878-87. PubMed ID: 19319944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus in head and neck cancers: biology, prognosis, hope of treatment, and vaccines.
    Psyrri A; Boutati E; Karageorgopoulou S
    Anticancer Drugs; 2011 Aug; 22(7):586-90. PubMed ID: 21403517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV-linked oral cancer: another argument for universal HPV vaccination of boys and girls.
    Laurence J
    AIDS Read; 2008 Jul; 18(7):345-6. PubMed ID: 18655309
    [No Abstract]   [Full Text] [Related]  

  • 20. Human papillomavirus and head and neck cancer: a growing concern.
    Gillespie MB; Smith J; Gibbs K; McRackan T; Rubinchik S; Day TA; Sutkowski N
    J S C Med Assoc; 2008 Dec; 104(8):247-51. PubMed ID: 19326612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.